Neurological complications of hemodialysis: State of the art

Journal of Nephrology

Volumn 25, Issue 2, 2012, Pages 170-182

  Rizzo, Maria Antonietta ^a,b   Frediani, Fabio ^a   Granata, Antonio ^c   Ravasi, Barbara ^a   Cusi, Daniele ^b   Gallieni, Maurizio ^a  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN GIOVANNI DI DIO HOSPITAL   (Italy)

Author keywords

Chronic kidney disease; Encephalopathy; Hemodialysis; Nervous system; Neurological complications; Uremia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE DERIVATIVE; BIOTIN; COBALAMIN; CORTICOSTEROID; DEFEROXAMINE; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; IMMUNOSUPPRESSIVE AGENT; IRON; NALFURAFINE; PYRIDOXINE; STEROID; THIAMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN D;

AMYLOIDOSIS; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; ATHEROSCLEROSIS; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE REGULATION; BRAIN ATROPHY; BRAIN HEMORRHAGE; CARPAL TUNNEL SYNDROME; CELL MEMBRANE PERMEABILITY; CENTRAL PONTINE MYELINOLYSIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; DECOMPRESSION; DEPRESSION; DIALYSIS ENCEPHALOPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DISEQUILIBRIUM SYNDROME; ELECTROENCEPHALOGRAPHY; GLOMERULUS FILTRATION RATE; GUILLAIN BARRE SYNDROME; HEMODIALYSIS; HEMODIALYSIS HEADACHE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERPARATHYROIDISM; HYPONATREMIA; ISCHEMIC MONOMELIC NEUROPATHY; MONONEUROPATHY; MYOCLONUS; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; OSMOSIS; PATHOGENESIS; PERIPHERAL NEUROPATHY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; RESTLESS LEGS SYNDROME; REVIEW; SEIZURE; SLEEP DISORDER; SPONDYLOARTHROPATHY; THIAMINE DEFICIENCY; TREATMENT DURATION; UREMIA; UREMIC ENCEPHALOPATHY; UREMIC MYOPATHY; UREMIC POLYNEUROPATHY; UREMIC PRURITUS; VASCULAR ACCESS; WERNICKE ENCEPHALOPATHY;

AUTONOMIC NERVOUS SYSTEM DISEASES; HUMANS; MONONEUROPATHIES; MYELINOLYSIS, CENTRAL PONTINE; NERVOUS SYSTEM DISEASES; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; RENAL DIALYSIS; SLEEP DISORDERS; WERNICKE ENCEPHALOPATHY;

EID: 84863302999     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000087     Document Type: Review

References (73)

1. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004;107(1):1-16.
2. De Deyn PP, Saxena VK, Abts H, et al. Clinical and pathophysiological aspects of neurological complications in renal failure. Acta Neurol Belg. 1992;92(4):191-206.
3. Rob PM, Niederstadt C, Reusche E. Dementia in patients undergoing long-term dialysis: aetiology, differential diagnoses, epidemiology and management. CNS Drugs. 2001;15(9): 691-699.
4. Mach JR Jr, Korchik WP, Mahowald MW. Dialysis dementia. Clin Geriatr Med. 1988;4(4):853-867.
5. Fukunishi I, Kitaoka T, Shirai T, Kino K, Kanematsu E, Sato Y. Psychiatric disorders among patients undergoing hemodialysis therapy. Nephron. 2002;91(2):344-347.
6. Lacerda G, Krummel T, Hirsch E. Neurologic presentations of renal diseases. Neurol Clin. 2010;28(1):45-59.
7. McKinney TD, Basinger M, Dawson E, Jones MM. Serum aluminum levels in dialysis dementia. Nephron. 1982;32(1): 53-56.
8. Kerr DN, Ward MK, Ellis HA, Simpson W, Parkinson IS. Aluminium intoxication in renal disease. Ciba Found Symp. 1992;169:123-135, discussion 135-141.
9. Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113(113):S1-S130.
10. Silver SM, Sterns RH, Halperin ML. Brain swelling after dialysis: old urea or new osmoles? Am J Kidney Dis. 1996;28(1):1-13.
11. Silver SM, DeSimone JA Jr, Smith DA, Sterns RH. Dialysis disequilibrium syndrome (DDS) in the rat: role of the "reverse urea effect". Kidney Int. 1992;42(1):161-166.
12. Patel N, Dalal P, Panesar M. Dialysis disequilibrium syndrome: a narrative review. Semin Dial. 2008;21(5):493-498.
13. Lopez-Almaraz E, Correa-Rotter R. Dialysis disequilibrium syndrome and other treatment complications of extreme uremia: a rare occurrence yet not vanished. Hemodial Int. 2008;12(3):301-306.
14. Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38(5):941-947
15. Kim J, Song T, Park S, Choi IS. Cerebellar peduncular myelinolysis in a patient receiving hemodialysis. J Neurol Sci. 2007;253(1-2):66-68.
16. Mahoney CA, Arieff AI. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis. 1982;2(3):324-336.
17. Bucurescu G. Neurological manifestations of uremic encephalopathy. Updated: Aug 17, 2010. Medscape Drugs, Diseases & Procedures. Available at: http://emedicine.medscape. com/article/1135651-overview. Accessed October 21, 2011.
18. Arieff AI, Mahoney CA. Pathogenesis of dialysis encephalopathy. Neurobehav Toxicol Teratol. 1983;5(6):641-644.
19. Vanholder R, De Smet R, Glorieux G, et al; European Uremic Toxin Work Group (EUTox). Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63(5):1934-1943.
20. Biasioli S, D'Andrea G, Chiaramonte S, et al. The role of neurotransmitters in the genesis of uremic encephalopathy. Int J Artif Organs. 1984;7(2):101-106.
21. Biasioli S, D'Andrea G, Fabris A, Feriani M, La Greca G. The pathogenesis of uremic encephalopathy (UE). Int J Artif Organs. 1985;8(1):59-60.
22. Iseki K, Fukiyama K. Okawa Dialysis Study (OKIDS) Group; The Okinawa Dialysis Study (OKIDS) Group. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. Nephrol Dial Transplant. 2000;15(11):1808-1813.
23. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58(1):353-362.
24. Iseki K, Fukiyama K. Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int. 1996;50(5):1672-1675.
25. Onoyama K, Ibayashi S, Nanishi F, et al. Cerebral hemorrhage in patients on maintenance hemodialysis: CT analysis of 25 cases. Eur Neurol. 1987;26(3):171-175.
26. Janssen MJ, van der Meulen J. The bleeding risk in chronic haemodialysis: preventive strategies in high-risk patients. Neth J Med. 1996;48(5):198-207.
27. Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J. 2001;77(903):24-28.
28. Hirasawa Y, Ogura T. Carpal tunnel syndrome in patients on long-term haemodialysis. Scand J Plast Surg Hand Surg. 2000;34(4):373-381.
29. Floege J, Ketteler M. beta2-Microglobulin-derived amyloidosis: an update. Kidney Int Suppl. 2001;78(s78):S164-S171.
30. Namazi H, Majd Z. Carpal tunnel syndrome in patients who are receiving long-term renal hemodialysis. Arch Orthop Trauma Surg. 2007;127(8):725-728.
31. Miles AM. Vascular steal syndrome and ischaemic monomelic neuropathy: two variants of upper limb ischaemia after haemodialysis vascular access surgery. Nephrol Dial Transplant. 1999;14(2):297-300.
32. Thermann F, Kornhuber M. Ischemic monomelic neuropathy: a rare but important complication after hemodialysis access placement: a review. J Vasc Access. 2011;12(2):113-119.
33. Malik J, Tuka V, Kasalova Z, et al. Understanding the dialysis access steal syndrome: a review of the etiologies, diagnosis, prevention and treatment strategies. J Vasc Access. 2008;9(3):155-166.
34. Basile C, Addabbo G, Montanaro A. Anterior ischemic optic neuropathy and dialysis: role of hypotension and anemia. J Nephrol. 2001;14:420-423.
35. Krishnan AV, Kiernan MC. Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve. 2007;35(3):273-290.
36. Galassi G, Ferrari S, Cobelli M, Rizzuto N. Neuromuscular complications of kidney diseases. Nephrol Dial Transplant. 1998;13(90007)(Suppl 7):41-47.
37. Mansouri B, Adybeig B, Rayegani M, Yasami S, Behshad V. Uremic neuropathy and the analysis of electrophysiological changes. Electromyogr Clin Neurophysiol. 2001;41(2): 107-115.
38. Göksan B, Karaali-Savrun F, Ertan S, Savrun M. Haemodialysis-related headache. Cephalalgia. 2004;24(4):284-287.
39. Milinkovic M, Zidverc-Trajkovic J, Sternic N, et al. Hemodialysis headache. Clin Nephrol. 2009;71(2):158-163.
40. The international classification of headache disorders. 2nd ed. Cephalalgia. 2004;24(Suppl 1):1-160.
41. Vita G, Messina C, Savica V, Bellinghieri G. Uraemic autonomic neuropathy. J Auton Nerv Syst. 1990;30(Suppl): S179-S184.
42. Chang MH, Chou KJ. The role of autonomic neuropathy in the genesis of intradialytic hypotension. Am J Nephrol. 2001;21(5):357-361.
43. Converse RL Jr, Jacobsen TN, Jost CM, et al. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest. 1992;90(5): 1657-1665.
44. Campistol JM. Uremic myopathy. Kidney Int. 2002;62(5): 1901-1913.
45. Harrison AP, Nielsen AH, Eidemak I, Molsted S, Bertles EM. The uremic environment and muscle dysfunction in man and rat. Nephron, Physiol. 2006;103(1):33-42.
46. Fahal IH, Bell GM, Bone JM, Edwards RH. Physiological abnormalities of skeletal muscle in dialysis patients. Nephrol Dial Transplant. 1997;12(1):119-127.
47. Kunis CL, Markowitz GS, Liu-Jarin X, Fisher PE, Frei GL, D'Agati VD. Painful myopathy and end-stage renal disease. Am J Kidney Dis. 2001;37(5):1098-1104.
48. Ponticelli C, Bencini PL. Pruritus in dialysis patients: a neglected problem. Nephrol Dial Transplant. 1995;10(12): 2174-2176.
49. Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis. 2007;50(1):11-20.
50. Narita I, Iguchi S, Omori K, Gejyo F. Uremic pruritus in chronic hemodialysis patients. J Nephrol. 2008;21(2):161-165.
51. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7(7): 535-547.
52. Schmelz M. A neural pathway for itch. Nat Neurosci. 2001;4(1):9-10.
53. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE. Specific C-receptors for itch in human skin. J Neurosci. 1997;17(20):8003-8008.
54. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci. 2001;4(1):72-77.
55. Aucella F, Vigilante M, Gesuete A, Maruccio G, Specchio A, Gesualdo L. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role? Nephrol Dial Transplant. 2007;22(Suppl 5):v8-v12.
56. Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant. 2004;19(12):3137-3139.
57. Wikström B, Gellert R, Ladefoged SD, et al. Kappa-opioid system in uremic pruritus: multicenter, randomized, doubleblind, placebo-controlled clinical studies. J Am Soc Nephrol. 2005;16(12):3742-3747.
58. Fusaro M, Munaretto G, Spinello M, Gallieni M. Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient. Nephrol Dial Transplant. 2004;19(5):1338-1339.
59. Frazão JM, Martins P. Adynamic bone disease: clinical and therapeutic implications. Curr Opin Nephrol Hypertens. 2009;18(4):303-307.
60. Giray S, Sagliker Y, Yildiz I, et al. Neurologic manifestations in Sagliker syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients. J Ren Nutr. 2006;16(3):233-236.
61. Martina V, Rizzo MA, Uggetti C, et al. CKD-MBD: un caso di devastanti complicanze vertebrali. Giornale di Tecniche Nefrologiche e Dialitiche. 2010;3:4-8.
62. Merlino G, Gigli GL, Valente M. Sleep disturbances in dialysis patients. J Nephrol. 2008;21(Suppl 13):S66-S70.
63. Merlino G, Piani A, Dolso P, et al. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant. 2006;21(1):184-190.
64. De Santo RM, Lucidi F, Violani C, Di Iorio BR. Sleep disorders in hemodialyzed patients: the role of comorbidities. Int J Artif Organs. 2005;28(6):557-565.
65. Krueger JM, Obal F Jr, Opp M, Toth L, Johannsen L, Cady AB. Somnogenic cytokines and models concerning their effects on sleep. Yale J Biol Med. 1990;63(2):157-172.
66. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis. 1996;28(3):372-378.
67. Satija P, Ondo WG. Restless legs syndrome: pathophysiology, diagnosis and treatment. CNS Drugs. 2008;22(6):497-518.
68. Fraser CL, Arieff AI. Nervous system complications in uremia. Ann Intern Med. 1988;109(2):143-153.
69. Laaksonen S, Metsärinne K, Voipio-Pulkki LM, Falck B. Neurophysiologic parameters and symptoms in chronic renal failure. Muscle Nerve. 2002;25(6):884-890.
70. Bolton CF, Remtulla H, Toth B, et al. Distinctive electrophysiological features of denervated muscle in uremic patients. J Clin Neurophysiol. 1997;14(6):539-542.
71. Lakadamyali H, Ergün T. MRI for acute neurologic complications in end-stage renal disease patients on hemodialysis. Diagn Interv Radiol. 2011;17(2):112-117.
72. Pirzada NA, Morgenlander JC. Peripheral neuropathy in patients with chronic renal failure: a treatable source of discomfort and disability. Postgrad Med. 1997;102(4):249-250, 255-257, 261.
73. Eknoyan G. Jean-Martin Charcot: neurologist by avocation, nephrologist by yearning. J Nephrol. 2011;24(Suppl 17): S4-S11.